What is the best antibiotic for treating uncomplicated cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Uncomplicated Cellulitis

For uncomplicated cellulitis, a cephalosporin (such as cephalexin), penicillin, or clindamycin is recommended as first-line therapy, with a 5-6 day course being as effective as longer treatment durations. 1

First-Line Antibiotic Selection

Standard Cases (No MRSA Risk Factors)

  • Antibiotics active against streptococci should be used for typical cases of cellulitis 1
  • Recommended oral options include:
    • Cephalexin 500 mg four times daily 1
    • Penicillin or amoxicillin 1
    • Dicloxacillin 1
    • Clindamycin 300-450 mg four times daily (especially for penicillin-allergic patients) 1, 2

Special Circumstances (MRSA Risk Factors)

  • Consider MRSA coverage when cellulitis is associated with:
    • Penetrating trauma, especially from illicit drug use 1
    • Evidence of MRSA infection elsewhere 1
    • Nasal colonization with MRSA 1
    • Injection drug use 1
    • Systemic inflammatory response syndrome (SIRS) 1
  • Options for MRSA coverage include:
    • Clindamycin (covers both streptococci and MRSA) 1
    • Trimethoprim-sulfamethoxazole (TMP-SMX) plus a β-lactam 1

Treatment Duration

  • A 5-6 day course of antibiotics is as effective as a 10-day course for uncomplicated cellulitis 1
  • The 2014 IDSA guideline recommends 5 days of therapy, with extension if the infection has not improved within this period 1
  • The 2019 NICE guideline recommends a course of 5-7 days 1
  • A randomized controlled trial showed no significant difference in clinical outcomes between 5 and 10 days of therapy with levofloxacin 3

Evidence Strength and Considerations

  • MRSA is an unusual cause of typical cellulitis without purulent drainage 1
  • A prospective study showed that β-lactam therapy was successful in 96% of patients with typical cellulitis, suggesting MRSA coverage is usually unnecessary 1
  • A randomized trial comparing cephalexin plus TMP-SMX versus cephalexin alone found no significant difference in clinical cure rates in the per-protocol analysis (83.5% vs 85.5%) 4
  • The activity of TMP-SMX against β-hemolytic streptococci is not well established, making it suboptimal as monotherapy 1

Adjunctive Measures

  • Elevation of the affected area hastens improvement by promoting gravity drainage of edema 1
  • Treat predisposing conditions such as tinea pedis, venous eczema, or trauma 1
  • Examine interdigital toe spaces in lower-extremity cellulitis to identify and treat fissuring or maceration 1
  • Systemic corticosteroids (prednisone 40 mg daily for 7 days) could be considered in non-diabetic adults with cellulitis 1

Monitoring and Follow-up

  • Patients should be monitored for clinical improvement within 48-72 hours of starting antibiotics 1, 5
  • Consider extending treatment if infection has not improved after 5 days 1
  • Hospitalization should be considered for patients with:
    • Signs of systemic toxicity 1
    • Altered mental status 1
    • Hemodynamic instability 1
    • Concern for deeper or necrotizing infection 1
    • Poor adherence to therapy 1
    • Severe immunocompromise 1
    • Failure of outpatient treatment 1

Common Pitfalls

  • Overuse of broad-spectrum antibiotics when narrow-spectrum options would be effective 1
  • Unnecessary MRSA coverage for typical cellulitis without risk factors 1
  • Prolonged antibiotic courses beyond 5-6 days when clinical improvement has occurred 1, 3
  • Failure to address underlying predisposing conditions 1
  • Not elevating the affected area to reduce edema and inflammation 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.